Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3133 of 6351
-
Can a smartphone app replace the gym for teens with arthritis?
Symptom relief CompletedJuvenile Idiopathic Arthritis (JIA) is a heterogeneous, idiopathic, chronic inflammatory, rheumatic disease that is most common in childhood and is thought to involve immunological mechanisms in its etiopathogenesis. Exercise and physical activity (PA) approaches have an importan…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 26, 2026 17:16 UTC
-
Could a simple nerve zap treat erectile dysfunction?
Symptom relief OngoingErectile dysfunction is known as any alteration that produces a modification in the erectile response, whether of organic, psychogenic or relational cause. In this case the pudendal nerve is addressed, since it has its origin in the sacral plexus, deriving from the S2, S3 and S4 …
Sponsor: Camilo Jose Cela University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat ovarian and uterine cancers
Disease control OngoingThis is a phase 1 study to evaluate investigational drug RP-6306 in combination with carboplatin and paclitaxel in patients with TP53 mutated ovarian or uterine cancer. The dose escalation part of the study will determine the maximum tolerated dose (MTD) and recommended Phase 2 D…
Phase 1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental drug aims to keep viral pneumonia patients out of hospital
Disease control Stopped earlyThis is a Phase II, multi-center, double-blind, randomized, interventional study in approximately 120 subjects to evaluate clinical benefit of CX-4945 in adult outpatients with SARS-CoV-2 and influenza viral infection-associated pneumonia. The subjects will be recruited into two …
Phase 2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Writing away the pain: new study tests expressive writing for LGBTQ+ veterans
Symptom relief Recruiting nowSexual minority stressors (e.g., sexual minority identity-based discrimination) contribute to greater risk for and severity of depression, anxiety, substance use disorders and suicide among sexual minority Veterans. However, no brief, scalable, one-on-one interventions targeting …
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Could an 'Exercise-in-a-Pill' replace workouts for heart failure?
Knowledge-focused Recruiting nowThe heart failure syndrome that occurs when the heart is too sick to properly do its job. One of the main symptoms is difficulty with exercise. One way to improve symptoms is to start patients in a 12 week exercise program called cardiac rehabilitation. Cardiac rehabilitation bee…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Could a common allergy drug boost brain power in kids with williams syndrome?
Disease control CompletedThis study focuses on therapeutic targets for cognitive, motor, and social impairments in Williams syndrome by reversing brain myelin defects caused by GTF2I. The primary objective of the study was to test and evaluate the initial efficacy and safety of Clomastine fumarate in the…
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Acupuncture needles vs. sepsis: a bold new trial
Symptom relief Recruiting nowResearchers think acupuncture may improve outcomes for participants with sepsis, based on laboratory studies and previous studies in people with sepsis. The purpose of this study to see whether real acupuncture can improve outcomes for participants with sepsis when compared to sh…
Phase 2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Tooth infection treatment showdown: MTA vs. standard sealers
Disease control CompletedThis project is a randomized controlled clinical study investigating the effect of Mineral Trioxide Aggregate (MTA) used as an apical plug in root canal obturation on periodontal healing and inflammatory biomarkers in teeth with combined endodontic-periodontal (endo-perio) lesion…
Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New depression pill shows promise in quick mood lift
Symptom relief CompletedTo evaluate the efficacy, safety, and tolerability of NBI-1070770 compared to placebo on improving symptoms of depression in participants with major depressive disorder (MDD).
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Art as medicine: study shows creative activities may ease anxiety and depression
Symptom relief CompletedStratified randomised controlled trial with two arms: arts intervention (any of the arts interventions, see list), which we call here Active Group (AG) vs waitlist control (WL).
Sponsor: KAVADIA ELENI • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can your sleep length predict the best insomnia cure?
Symptom relief Recruiting nowIndividuals who have insomnia with short sleep duration (ISS) differ from individuals who have insomnia with normal sleep duration (INS) in terms of health risks (i.e., hypertension) and treatment response. This study will examine whether patients with ISS and INS demonstrate a d…
Early phase 1 • Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Blood test may spot kidney disease relapse
Diagnosis Recruiting nowThis retrospective study is aimed at evaluating the levels of circulating anti-nephrin autoantibodies in patients with INS, including those with MCD/FSGS and in patients who have experienced relapse of FSGS post-transplant, compared to those of a control group of patients with ne…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Diagnosis
Last updated Jun 26, 2026 13:46 UTC
-
Can a tailored mediterranean diet and exercise reverse fatty liver?
Disease control CompletedThe study in question is an interventional study with nutritional intervention. The aim of the study is to evaluate whether the adoption of two different models of Mediterranean Diet, based on the different percentage of carbohydrates and lipids, associated with a program of mod…
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Smartwatch could spot hidden heart flutters after surgery
Knowledge-focused Recruiting nowThe objective of this single-center pilot study is, with the help of a connected watch, to show the absence of recurrence or maintenance of sinus rhythm in patients with a Post Operative Atrial Fibrillation (POAF) and to help treating cardiologists in the care of these patients.
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New hope for rare artery disease? small trial tests upadacitinib
Disease control CompletedTakayasu arteritis (TKA) is an autoimmune vasculitis characterized with involvement of aorta and its primary branches.Upadacitinib is an oral, selective JAK1 inhibitor that potently inhibits JAK1 activity, representing a potential therapeutic option.This study aims to assess the …
Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Text alerts could save transplanted organs in young patients
Disease control OngoingCan the investigators create an effective way to improve adherence to immunosuppressant medication and reduce rejection, graft loss, and death in adolescents and young adults who have undergone kidney or liver transplantation? The investigators' mobile technology intervention use…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New weight loss shot shows promise in early human testing
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, single-dose, dose-escalation Phase Ia clinical study. It is aimed to evaluate the safety, tolerability, PK and PD characteristics of HDM1005 injection in healthy adult subjects.
Phase 1 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a simple online questionnaire help rural smokers kick the habit?
Disease control By invitation onlyThe purpose of this study is to evaluate an electronic visit (e-visit) for COPD screening and for quitting smoking. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about…
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
AI joins the fight against atrial fibrillation
Knowledge-focused Recruiting nowObservational, multi-center, clinical device registry for US patients with a primary goal to observe the clinical outcomes in patients who are mapped with Volta Medical's VX1 or AF-Xplorer systems during AF ablation procedures.
Sponsor: Volta Medical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC